Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccines.

Samankaltaisia teoksia

• Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG.
  Tekijä: Alonso de Velasco, E, et al.
  Julkaistu: (1994)
• Modulation of the immune response to pneumococcal type 14 capsular polysaccharide-protein conjugates by the adjuvant Quil A depends on the properties of the conjugates.
  Tekijä: Verheul, A F, et al.
  Julkaistu: (1989)
• Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
  Tekijä: Hoffman, Thijs W., et al.
  Julkaistu: (2020)
• Synthetic 6B Di-, Tri-, and Tetrasaccharide-Protein Conjugates Contain Pneumococcal Type 6A and 6B Common and 6B- Specific Epitopes That Elicit Protective Antibodies in Mice
  Tekijä: Jansen, Wouter T. M., et al.
  Julkaistu: (2001)
• The Pneumococcal Polysaccharide-Tetanus Toxin Native C-Fragment Conjugate Vaccine: The Carrier Effect and Immunogenicity
  Tekijä: Yu, Rui, et al.
  Julkaistu: (2020)